📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ACE inhibitors and ARBs: Managing potassium and renal function. (2019)

First Author: Momoniat T

Attributed to: Multi-centre Randomized Controlled Trial of angiotensin converting enzyme inhibitor (ACEi) /angiotensin receptor blocker (ARB) - withdrawal in chronic kidney disease – STOP-ACEi-STUDY (SAS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3949/ccjm.86a.18024

PubMed Identifier: 31498767

Publication URI: http://europepmc.org/abstract/MED/31498767

Type: Journal Article/Review

Volume: 86

Parent Publication: Cleveland Clinic journal of medicine

Issue: 9

ISSN: 0891-1150